1. Scrip code : 517536
Name : Onward Technologies Ltd.
Subject : Board to consider Dividend
Onward Technologies Ltd has informed BSE that a meeting of the Board of Directors of the Company shall be convened on May 15, 2020 via Video Conferencing as per the provisions given in Companies (Meetings of Board and its Powers) Rules, 2014 Rule (4) sub-rule (1) may be held through video conferencing or other audio visual means in accordance with Rule 3 (MCA Notification as on March 19th, 2020) and following agenda items be discussed: 1. To consider and take on record the audited financial results along with draft Audit Report of the Company for the quarter and year ended March 31, 2020. 2. To propose merger of Onward eServices Limited, being wholly owned subsidiary along with Onward Technologies Limited. 3. To adopt Directors Report along with its annexures for financial year ended March 31, 2020. 4. To consider re-appointment of Independent Director for second term. 5. To consider Appointment of Additional Directors (Independent, Non-Executive). 6. To recommend declaration of Dividend. Further, the trading window has been closed w.e.f. April 01, 2020 till May 19, 2020. The trading window shall open from May 20, 2020.
2. Scrip code : 530175
Name : Odyssey Technologies Ltd.
Subject : Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
This is to inform that the Honorable National Company Law Tribunal (NCLT), Chennai vide Order dated May 5, 2020, (received by us on May 6, 2020) have approved the Scheme of Amalgamation of Cyberneme Private Limited (Transferor Company) with Odyssey Technologies Limited (Transferee Company) and their respective shareholders and creditors pursuant to Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. The Appointed Date of the Scheme is December 1, 2018. The certified true copy of the Order will be filed with the Registrar of Companies, Chennai.
3. Scrip code : 537291
Name : Nath Biogene India Ltd.
Subject : Announcement under Regulation 30 (LODR)-Acquisition
Acquisition of Technology from Global Transgenes Limited Associate Company of Nath Bio-Genes (India) Limited.
4. Scrip code : 505800
Name : Rane Holdings Ltd.
Subject : Clarification
This has reference to our letter no(s). RHL/SE/64/2019-20 dated March 23, 2020 intimating the acquisition of 5,80,720 equity shares of Rs.10 each fully paid up (1.78%) in our subsidiary company viz., Rane (Madras) Limited (RML) arising on conversion of 5,80,720 warrants (partial conversion of the 17,42,160 warrants) into underlying equity shares. In the said intimation it was inadvertently mentioned that ‘the balance 11,61,440 warrants are eligible for conversion on or before June 17, 2020’, instead of June 17,2021. Please note that the balance 11,61,440 warrants are eligible for conversion into equivalent number of equity shares in RML on or before June 17,2021. The error is regretted. We request you to take the above on record.